Lexaria Bioscience Corp. (LEXX) Earnings
|
Expand Research on LEXX
| Next EPS Date | 7/20/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -4.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/14/26  |
Q226 | N/A | -$0.10 | N/A | N/A | $100K | N/A | N/A | N/A | ||
| 1/21/26 |
Q126 | N/A | -$0.17 | N/A | N/A | $100K | N/A | N/A | N/A | ||
| 1/26/26 |
Q126 | N/A | -$0.17 | N/A | N/A | $100K | N/A | N/A | N/A | ||
| 10/29/25 |
Q425 | N/A | -$0.16 | N/A | N/A | $137K | N/A | N/A | N/A | ||
| 7/28/25 |
Q325 | N/A | -$0.16 | N/A | N/A | $137K | N/A | N/A | N/A | ||
| 7/24/25 |
Q325 | N/A | -$0.16 | N/A | N/A | $137K | N/A | N/A | N/A | ||
| 7/22/25 |
Q325 | N/A | -$0.16 | N/A | N/A | $137K | N/A | N/A | N/A | ||
| 7/21/25 |
Q325 | N/A | -$0.16 | N/A | N/A | $137K | N/A | N/A | N/A |
